Statement |

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

Read MSF's submission to the United States Trade Representative on the 2014 Special 301 review process, which affects accessibility of medicines and important diagnostic tools, highlighting in particular the effects of the Special 301 review for India.